[Objectives]This study aimed to investigate the pathogenicity,growth characteristics and drug resistance of Streptococcus suis type 2.[Methods]Bacterial isolation and identification,biochemical experiments,determinati...[Objectives]This study aimed to investigate the pathogenicity,growth characteristics and drug resistance of Streptococcus suis type 2.[Methods]Bacterial isolation and identification,biochemical experiments,determination of growth curve and correlation curve between OD 600 values and viable counts,drug susceptibility tests,pathogenicity analysis,and histopathological observations were carried out.[Results]The Streptococcus strain isolated from infected pigs was identified as Streptococcus suis type 2,which was named TA01 strain.TA01 strain reached the growth peak at 6-8 h post-incubation,and viable counts gradually declined after 8 h of incubation.The correlation equation between OD 600 values and viable counts is y=24.659 x-1.076 1,R^2=0.996 7.TA01 strain was sensitive to penicillin,erythromycin,florfenicol and oxacillin,and resistant to ciprofloxacin,polymyxin B and clindamycin.According to the results of pathogenicity analysis,all the mice in 3.6×10^9 cfu/mouse group died within 48,and these dead mice exhibited acute pyaemia septica.Based on the Reed-Muench formula,it was calculated that LD 50 of TA01 strain was 1.137×10^8 cfu/mouse.Pathological examination showed obvious blue-stained bacteria clusters,accompanied by neutrophil infiltration.[Conclusions]TA01 strain was a virulent strain of Streptococcus suis type 2.Compared with Streptococcus strains which were isolated and reported in China,TA01 strain exhibited strong virulence and rapid proliferation.展开更多
Streptococcus suis is an important pathogen in pigs. Transmission of this pathogen is generally believed to occur between healthy carrier sows and their offspring, so the carrier status of S. suis in healthy sows is i...Streptococcus suis is an important pathogen in pigs. Transmission of this pathogen is generally believed to occur between healthy carrier sows and their offspring, so the carrier status of S. suis in healthy sows is important for the control of S. suis infections in pigs, especially in suckling and growing pigs. In this study, the prevalence of S. suis isolated from clinically healthy sows in China was studied for the first time. A total of 1 043 tonsil samples were collected from clinically healthy sows from 10 regions in China from 2005 to 2007. Among the 421 S. suis isolates, 31 strains were identified as capsular type 2. The results showed that S. suis was widespread in swine herds in China with the carrier rates in different herds ranging from 19.5 to 93.9%. Overall, 40.4 and 3.0% of clinically healthy sows harbored S. suis and capsular type 2 in their palatine tonsils, respectively. Statistically significant differences of carrier rates of S. suis and capsular type 2 between the different farms were observed, which was independent of herd sizes and geographic distributions of different herds.展开更多
猪链球菌(Streptococcus suis,SS)是一种重要的人畜共患病原体,猪链球菌2型(Streptococcus suis type 2,SS2)1954年首次在英国分离鉴定,在我国和其他养猪业发达的国家已多次流行,已成为危害我国养猪业和公共卫生安全的一个重要传染病。...猪链球菌(Streptococcus suis,SS)是一种重要的人畜共患病原体,猪链球菌2型(Streptococcus suis type 2,SS2)1954年首次在英国分离鉴定,在我国和其他养猪业发达的国家已多次流行,已成为危害我国养猪业和公共卫生安全的一个重要传染病。本研究用SS2-ZY05719株按10^(9)、10^(8)、10^(6)CFU腹腔注射途径人工感染健康的新西兰兔,3种剂量均可引起发病并死亡,新西兰兔临床症状明显,感染组平均体温升高1℃~2℃。同时分析了SS2在兔体各组织中的分布,结果显示,高剂量感染组出现明显的临床症状且快速死亡,感染剂量与发病程度有正相关性,对各试验组新西兰兔内脏组织进行检测发现,SS2主要集中在心脏、肝脏、脾脏、肺脏、肾脏和脑等组织中,不同组织器官中的细菌载量也存在着一定的差异,本文研究了SS2感染新西兰兔后的临床症状和各组织载菌量,为猪链球菌的防治及致病机理研究提供参考。展开更多
构建猪链球菌2型(Streptococcus suis type 2)强毒株05ZYH33二元信号转导系统2148hk/rr基因敲除突变体。构建中间为壮观霉素抗性基因,两侧为2148hk/rr编码基因上、下游同源序列的基因敲除质粒,通过同源重组筛选2148hk/rr编码基因敲除突...构建猪链球菌2型(Streptococcus suis type 2)强毒株05ZYH33二元信号转导系统2148hk/rr基因敲除突变体。构建中间为壮观霉素抗性基因,两侧为2148hk/rr编码基因上、下游同源序列的基因敲除质粒,通过同源重组筛选2148hk/rr编码基因敲除突变体。PCR分析和Southern杂交结果均显示2148hk/rr编码基因完全被壮观霉素抗性基因替代,基因敲除突变体构建成功。筛选获得05ZYH33二元信号转导系统2148hk/rr基因敲除突变体,为阐明该调控系统在猪链球菌致病过程中的作用奠定了基础。展开更多
试验旨在研制具有高抗原活性的猪链球菌2型(Streptococcus suis type 2,SS2)疫苗培养基。研究以SS2 CVCC60615株为试验对象,通过单因素试验、Plackett-Burman试验、最陡爬坡试验和响应面分析得到SS2疫苗培养基。培养基发酵验证结果显示,...试验旨在研制具有高抗原活性的猪链球菌2型(Streptococcus suis type 2,SS2)疫苗培养基。研究以SS2 CVCC60615株为试验对象,通过单因素试验、Plackett-Burman试验、最陡爬坡试验和响应面分析得到SS2疫苗培养基。培养基发酵验证结果显示,SS2疫苗培养基菌液最大活菌数为1.09×10^(9) CFU/mL,是TSB培养基最大活菌数的2.41倍。测定SS2不同时间点的抗原活性发现,在SS2发酵培养过程中当活菌数达到最大值后的1~3 h内细菌的抗原活性最高。小鼠感染试验表明,SS2抗原活性最高时制备的灭活疫苗与商品化灭活疫苗相比具有更高的免疫球蛋白G(IgG)抗体效价和疫苗保护率。研究表明,采用研制得到的高抗原活性SS2疫苗培养基制备的灭活疫苗具有IgG抗体效价高、免疫保护力强的优点。展开更多
基金Supported by National Key Basic Research Program of China(973 Program)(2017YFD0500605)
文摘[Objectives]This study aimed to investigate the pathogenicity,growth characteristics and drug resistance of Streptococcus suis type 2.[Methods]Bacterial isolation and identification,biochemical experiments,determination of growth curve and correlation curve between OD 600 values and viable counts,drug susceptibility tests,pathogenicity analysis,and histopathological observations were carried out.[Results]The Streptococcus strain isolated from infected pigs was identified as Streptococcus suis type 2,which was named TA01 strain.TA01 strain reached the growth peak at 6-8 h post-incubation,and viable counts gradually declined after 8 h of incubation.The correlation equation between OD 600 values and viable counts is y=24.659 x-1.076 1,R^2=0.996 7.TA01 strain was sensitive to penicillin,erythromycin,florfenicol and oxacillin,and resistant to ciprofloxacin,polymyxin B and clindamycin.According to the results of pathogenicity analysis,all the mice in 3.6×10^9 cfu/mouse group died within 48,and these dead mice exhibited acute pyaemia septica.Based on the Reed-Muench formula,it was calculated that LD 50 of TA01 strain was 1.137×10^8 cfu/mouse.Pathological examination showed obvious blue-stained bacteria clusters,accompanied by neutrophil infiltration.[Conclusions]TA01 strain was a virulent strain of Streptococcus suis type 2.Compared with Streptococcus strains which were isolated and reported in China,TA01 strain exhibited strong virulence and rapid proliferation.
基金supported by the National Key Tech-nologies R&D Program of China (2004BA519A60,2006BAK02A03-1)
文摘Streptococcus suis is an important pathogen in pigs. Transmission of this pathogen is generally believed to occur between healthy carrier sows and their offspring, so the carrier status of S. suis in healthy sows is important for the control of S. suis infections in pigs, especially in suckling and growing pigs. In this study, the prevalence of S. suis isolated from clinically healthy sows in China was studied for the first time. A total of 1 043 tonsil samples were collected from clinically healthy sows from 10 regions in China from 2005 to 2007. Among the 421 S. suis isolates, 31 strains were identified as capsular type 2. The results showed that S. suis was widespread in swine herds in China with the carrier rates in different herds ranging from 19.5 to 93.9%. Overall, 40.4 and 3.0% of clinically healthy sows harbored S. suis and capsular type 2 in their palatine tonsils, respectively. Statistically significant differences of carrier rates of S. suis and capsular type 2 between the different farms were observed, which was independent of herd sizes and geographic distributions of different herds.
文摘猪链球菌(Streptococcus suis,SS)是一种重要的人畜共患病原体,猪链球菌2型(Streptococcus suis type 2,SS2)1954年首次在英国分离鉴定,在我国和其他养猪业发达的国家已多次流行,已成为危害我国养猪业和公共卫生安全的一个重要传染病。本研究用SS2-ZY05719株按10^(9)、10^(8)、10^(6)CFU腹腔注射途径人工感染健康的新西兰兔,3种剂量均可引起发病并死亡,新西兰兔临床症状明显,感染组平均体温升高1℃~2℃。同时分析了SS2在兔体各组织中的分布,结果显示,高剂量感染组出现明显的临床症状且快速死亡,感染剂量与发病程度有正相关性,对各试验组新西兰兔内脏组织进行检测发现,SS2主要集中在心脏、肝脏、脾脏、肺脏、肾脏和脑等组织中,不同组织器官中的细菌载量也存在着一定的差异,本文研究了SS2感染新西兰兔后的临床症状和各组织载菌量,为猪链球菌的防治及致病机理研究提供参考。
文摘构建猪链球菌2型(Streptococcus suis type 2)强毒株05ZYH33二元信号转导系统2148hk/rr基因敲除突变体。构建中间为壮观霉素抗性基因,两侧为2148hk/rr编码基因上、下游同源序列的基因敲除质粒,通过同源重组筛选2148hk/rr编码基因敲除突变体。PCR分析和Southern杂交结果均显示2148hk/rr编码基因完全被壮观霉素抗性基因替代,基因敲除突变体构建成功。筛选获得05ZYH33二元信号转导系统2148hk/rr基因敲除突变体,为阐明该调控系统在猪链球菌致病过程中的作用奠定了基础。
文摘试验旨在研制具有高抗原活性的猪链球菌2型(Streptococcus suis type 2,SS2)疫苗培养基。研究以SS2 CVCC60615株为试验对象,通过单因素试验、Plackett-Burman试验、最陡爬坡试验和响应面分析得到SS2疫苗培养基。培养基发酵验证结果显示,SS2疫苗培养基菌液最大活菌数为1.09×10^(9) CFU/mL,是TSB培养基最大活菌数的2.41倍。测定SS2不同时间点的抗原活性发现,在SS2发酵培养过程中当活菌数达到最大值后的1~3 h内细菌的抗原活性最高。小鼠感染试验表明,SS2抗原活性最高时制备的灭活疫苗与商品化灭活疫苗相比具有更高的免疫球蛋白G(IgG)抗体效价和疫苗保护率。研究表明,采用研制得到的高抗原活性SS2疫苗培养基制备的灭活疫苗具有IgG抗体效价高、免疫保护力强的优点。
